• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触二甲基胂酸(无机砷的一种主要代谢产物)会强烈促进由4-硝基喹啉-1-氧化物引发的小鼠肺部肿瘤发生。

Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice.

作者信息

Yamanaka K, Ohtsubo K, Hasegawa A, Hayashi H, Ohji H, Kanisawa M, Okada S

机构信息

Department of Biochemical Toxicology, Nihon University College of Pharmacy, Chiba, Japan.

出版信息

Carcinogenesis. 1996 Apr;17(4):767-70. doi: 10.1093/carcin/17.4.767.

DOI:10.1093/carcin/17.4.767
PMID:8625489
Abstract

The effect of dimethylarsenics on the pulmonary tumorigenesis initiated by 4-nitroquinoline 1-oxide (4NQO) in mice was examined. The exposure of mice to dimethylarsinic acid (DMAA), a major metabolite of inorganic arsenics in mammals, resulted in not only promotion but also progression of the tumorigenic process in the lungs of mice administered 4NQO. Furthermore, dimethylarsenics influenced the differentiation process in lung tumorigenesis by 4NQO. These results may pave the way for the elucidation of lung carcinogenesis caused by arsenics.

摘要

研究了二甲基砷对4-硝基喹啉-1-氧化物(4NQO)引发的小鼠肺肿瘤发生的影响。将小鼠暴露于无机砷在哺乳动物中的主要代谢产物二甲基砷酸(DMAA),不仅导致给予4NQO的小鼠肺部肿瘤发生过程的促进,还导致其进展。此外,二甲基砷影响了4NQO所致肺肿瘤发生中的分化过程。这些结果可能为阐明砷引起的肺癌发生铺平道路。

相似文献

1
Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice.接触二甲基胂酸(无机砷的一种主要代谢产物)会强烈促进由4-硝基喹啉-1-氧化物引发的小鼠肺部肿瘤发生。
Carcinogenesis. 1996 Apr;17(4):767-70. doi: 10.1093/carcin/17.4.767.
2
Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice.二甲基胂酸是无机砷的主要代谢产物,对A/J小鼠的肺部肿瘤具有致瘤性和促进肿瘤进展的作用。
Cancer Lett. 1998 Mar 13;125(1-2):83-8. doi: 10.1016/s0304-3835(97)00484-9.
3
Effects of glycerol on 4-nitroquinoline 1-oxide induced pulmonary tumorigenesis in ddY mice.
Jpn J Cancer Res. 1986 Feb;77(2):103-5.
4
Promoting action of glycerol in pulmonary tumorigenesis model using a single administration of 4-nitroquinoline 1-oxide in mice.
Jpn J Cancer Res. 1986 Apr;77(4):345-50.
5
72-kDa stress protein (hsp72) induced by administration of dimethylarsinic acid to mice accumulates in alveolar flat cells of lung, a target organ for arsenic carcinogenesis.
Biol Pharm Bull. 2000 Oct;23(10):1212-5. doi: 10.1248/bpb.23.1212.
6
Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis.无机砷的主要代谢产物二甲基胂酸经口暴露于小鼠会导致8-氧代-2'-脱氧鸟苷水平升高,特别是在砷致癌作用的靶器官中。
Biochem Biophys Res Commun. 2001 Sep 14;287(1):66-70. doi: 10.1006/bbrc.2001.5551.
7
Cell-nuclear accumulation of 72-kDa stress protein induced by dimethylated arsenics.二甲基砷诱导的72 kDa应激蛋白在细胞核内的积累。
Biol Pharm Bull. 1997 Apr;20(4):364-9. doi: 10.1248/bpb.20.364.
8
The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress.三价二甲基砷在小鼠二甲基次砷酸促进皮肤和肺部肿瘤发生中的作用:通过诱导氧化应激发挥促肿瘤作用。
Toxicol Lett. 2005 Aug 14;158(2):87-94. doi: 10.1016/j.toxlet.2005.03.009. Epub 2005 Apr 14.
9
Is vitamin E a useful agent to protect against oxy radical-promoted lung tumorigenesis in ddY mice?维生素E是否是一种有效的药物,可预防ddY小鼠中氧自由基促进的肺癌发生?
Carcinogenesis. 1993 Jun;14(6):1133-6. doi: 10.1093/carcin/14.6.1133.
10
[Inhibition of (-)epigallocatechin gallate on dimethylarsinic acid promoting lung tumorigenesis through the induction of oxidative stress in mice].
Wei Sheng Yan Jiu. 2008 Nov;37(6):748-50.

引用本文的文献

1
Risk assessment of small organoarsenic species in food.食品中有机小分子砷物种的风险评估。
EFSA J. 2024 Jul 2;22(7):e8844. doi: 10.2903/j.efsa.2024.8844. eCollection 2024 Jul.
2
Pharmacokinetic Properties of Arsenic Species after Intravenous and Intragastrical Administration of Arsenic Trioxide Solution in Cynomolgus Macaques Using HPLC-ICP-MS.高效液相色谱-电感耦合等离子体质谱法研究三氧化二砷溶液在食蟹猴静脉注射和灌胃给药后的药代动力学特征。
Molecules. 2019 Jan 10;24(2):241. doi: 10.3390/molecules24020241.
3
Tumor-augmenting effects of gestational arsenic exposure on F1 and F2 in mice.
孕期砷暴露对小鼠F1和F2代的肿瘤促进作用。
Genes Environ. 2017 Mar 1;39:3. doi: 10.1186/s41021-016-0069-1. eCollection 2017.
4
Pharmacokinetic and Genomic Effects of Arsenite in Drinking Water on Mouse Lung in a 30-Day Exposure.饮用水中砷酸盐对小鼠肺脏30天暴露的药代动力学和基因组效应
Dose Response. 2015 Jun 30;13(2):1559325815592392. doi: 10.1177/1559325815592392. eCollection 2015 Apr-Jun.
5
Arsenic exposure and toxicology: a historical perspective.砷暴露与毒理学:历史视角。
Toxicol Sci. 2011 Oct;123(2):305-32. doi: 10.1093/toxsci/kfr184. Epub 2011 Jul 12.
6
Multiscale assessment of methylarsenic reactivity in soil. 2. Distribution and speciation in soil.土壤中甲基砷反应性的多尺度评估。2. 土壤中的分布和形态。
Environ Sci Technol. 2011 May 15;45(10):4300-6. doi: 10.1021/es103577e. Epub 2011 Apr 13.
7
Cancer in experimental animals exposed to arsenic and arsenic compounds.实验动物暴露于砷及砷化合物后发生的癌症。
Crit Rev Toxicol. 2010 Nov;40(10):912-27. doi: 10.3109/10408444.2010.506641.
8
Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.口服给药后小鼠体内五价和三价二甲基砷的组织剂量测定、代谢及排泄
Toxicol Appl Pharmacol. 2008 Feb 15;227(1):26-35. doi: 10.1016/j.taap.2007.10.011. Epub 2007 Oct 22.
9
Carcinogenicity of dimethylarsinic acid in Ogg1-deficient mice.二甲基次胂酸对Ogg1基因缺陷小鼠的致癌性。
Cancer Sci. 2007 Jun;98(6):803-14. doi: 10.1111/j.1349-7006.2007.00475.x. Epub 2007 Apr 18.
10
Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.肝细胞中亚砷酸盐摄取与代谢的药代动力学建模——机理见解及对进一步实验的启示
J Pharmacokinet Pharmacodyn. 2002 Jun;29(3):207-34. doi: 10.1023/a:1020248922689.